Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis.

ABSTRACT: BACKGROUND:Digital health programs assist patients with chronic obstructive pulmonary disease (COPD) to better manage their disease. Technological and adoption barriers have been perceived as a limitation. OBJECTIVE:The aim of the research was to evaluate a digital quality improvement pilot in Medicare-eligible patients with COPD. METHODS:COPD patients were enrolled in a digital platform to help manage their medications and symptoms as part of their routine clinical care. Patients were provided with electronic medication monitors (EMMs) to monitor short-acting beta-agonist (SABA) use passively and a smartphone app to track use trends and receive feedback. Providers also had access to data collected via a secure website and were sent email notifications if a patient had a significant change

SUBMITTER: Chen J 

PROVIDER: S-EPMC7010108 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature